Hematopoietic MyD88-adaptor Protein Acts as a Natural Defense Mechanism for Cognitive Deficits in Alzheimer's Disease

Stem Cell Reviews and Reports

Volumn 8, Issue 3, 2012, Pages 898-904

  Michaud, Jean Philippe ^a   Richard, Karine L ^a   Rivest, Serge ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Alzheimer's disease; Chemokines; Cytokines; Inflammation; Innate immunity; Microglia

Indexed keywords

AMYLOID; AMYLOID BETA PROTEIN; MYD88 PROTEIN, MOUSE; MYELOID DIFFERENTIATION FACTOR 88;

ALZHEIMER DISEASE; ANIMAL; ARTICLE; BONE MARROW TRANSPLANTATION; C57BL MOUSE; CELL CULTURE; COGNITION; COGNITIVE DEFECT; GENETICS; IMMUNOLOGY; INNATE IMMUNITY; MAZE TEST; METABOLISM; MICROGLIA; MOUSE; PATHOLOGY; PHAGOCYTOSIS; PHYSIOLOGY; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; AMYLOID; AMYLOID BETA-PEPTIDES; ANIMALS; BONE MARROW TRANSPLANTATION; CELLS, CULTURED; COGNITION; COGNITION DISORDERS; IMMUNITY, INNATE; MAZE LEARNING; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROGLIA; MYELOID DIFFERENTIATION FACTOR 88; PHAGOCYTOSIS; SIGNAL TRANSDUCTION;

MUS;

EID: 84865563936     PISSN: 15508943     EISSN: 15586804     Source Type: Journal    
DOI: 10.1007/s12015-012-9356-9     Document Type: Article

References (27)

1. Hardy, J. A., & Higgins, G. A. (1992). Alzheimer's disease: the amyloid cascade hypothesis. Science, 256(5054), 184-185.
2. Wyss-Coray, T. (2006). Inflammation in Alzheimer disease: driving force, bystander or beneficial response? Nature Medicine, 12(9), 1005-1015.
3. Hess, D. C., Abe, T., Hill, W. D., et al. (2004). Hematopoietic origin of microglial and perivascular cells in brain. Experimental Neurology, 186(2), 134-144.
4. Priller, J., Flügel, A., Wehner, T., et al. (2001). Targeting gene-modified hematopoietic cells to the central nervous system: use of green fluorescent protein uncovers microglial engraftment. Nature Medicine, 7(12), 1356-1361.
5. Priller, J., Prinz, M., Heikenwalder, M., et al. (2006). Early and rapid engraftment of bone marrow-derived microglia in scrapie. Journal of Neuroscience, 26(45), 11753-11762.
6. Simard, A. R., & Rivest, S. (2004). Bone marrow stem cells have the ability to populate the entire central nervous system into fully differentiated parenchymal microglia. The FASEB Journal, 18(9), 998-1000.
7. Simard, A. R., Soulet, D., Gowing, G., Julien, J.-P., & Rivest, S. (2006). Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease. Neuron, 49(4), 489-502.
8. Vallières, L., & Sawchenko, P. E. (2003). Bone marrow-derived cells that populate the adult mouse brain preserve their hematopoietic identity. Journal of Neuroscience, 23(12), 5197-5207.
9. Kawai, T., & Akira, S. (2010). The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nature Immunology, 11(5), 373-384.
10. Frank, S., Copanaki, E., Burbach, G. J., Müller, U. C., & Deller, T. (2009). Differential regulation of toll-like receptor mRNAs in amyloid plaque-associated brain tissue of aged APP23 transgenic mice. Neuroscience Letters, 453(1), 41-44.
11. Reed-Geaghan, E. G., Savage, J. C., Hise, A. G., & Landreth, G. E. (2009). CD14 and toll-like receptors 2 and 4 are required for fibrillar A{beta}-stimulated microglial activation. Journal of Neuroscience, 29(38), 11982-11992.
12. Doi, Y., Mizuno, T., Maki, Y., et al. (2009). Microglia activated with the toll-like receptor 9 ligand CpG attenuate oligomeric amyloid beta neurotoxicity in in vitro and in vivo models of Alzheimer's disease. American Journal of Pathology, 175(5), 2121-2132.
13. Tahara, K., Kim, H.-D., Jin, J.-J., Maxwell, J. A., Li, L., & Fukuchi, K.-I. (2006). Role of toll-like receptor signalling in Abeta uptake and clearance. Brain, 129(Pt 11), 3006-3019.
14. Richard, K. L., Filali, M., Préfontaine, P., & Rivest, S. (2008). Toll-like receptor 2 acts as a natural innate immune receptor to clear amyloid beta 1-42 and delay the cognitive decline in a mouse model of Alzheimer's disease. Journal of Neuroscience, 28(22), 5784-5793.
15. Michaud, J.-P., Richard, K. L., & Rivest, S. (2011). MyD88-adaptor protein acts as a preventive mechanism for memory deficits in a mouse model of Alzheimer's disease. Molecular Neurodegeneration, 6(1), 5.
16. Stine, W. B., Dahlgren, K. N., Krafft, G. A., & LaDu, M. J. (2003). In vitro characterization of conditions for amyloid-beta peptide oligomerization and fibrillogenesis. Journal of Biological Chemistry, 278(13), 11612-11622.
17. Kang, J., & Rivest, S. (2007). MyD88-deficient bone marrow cells accelerate onset and reduce survival in a mouse model of amyotrophic lateral sclerosis. The Journal of Cell Biology, 179(6), 1219-1230.
18. Filali, M., & Lalonde, R. (2009). Age-related cognitive decline and nesting behavior in an APPswe/PS1 bigenic model of Alzheimer's disease. Brain Research, 1292, 93-99.
19. Streit, W. J. (2006). Microglial senescence: does the brain's immune system have an expiration date? Trends in Neurosciences, 29(9), 506-510.
20. Jimenez, S., Baglietto-Vargas, D., Caballero, C., et al. (2008). Inflammatory response in the hippocampus of PS1M146L/APP751SL mouse model of Alzheimer's disease: age-dependent switch in the microglial phenotype from alternative to classic. Journal of Neuroscience, 28(45), 11650-11661.
21. Fiala, M., Lin, J., Ringman, J., et al. (2005). Ineffective phagocytosis of amyloid-beta by macrophages of Alzheimer's disease patients. Journal of Alzheimer's Disease, 7(3), 221-32. discussion 255-62.
22. Benilova I, Karran E, De Strooper B. The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes. Nat Neurosci 2012;: 1-9.
23. Chen, K., Iribarren, P., Hu, J., et al. (2006). Activation of Toll-like receptor 2 on microglia promotes cell uptake of Alzheimer disease-associated amyloid beta peptide. Journal of Biological Chemistry, 281(6), 3651-3659.
24. Liu, Y., Walter, S., Stagi, M., et al. (2005). LPS receptor (CD14): a receptor for phagocytosis of Alzheimer's amyloid peptide. Brain, 128(Pt 8), 1778-1789.
25. Sanjuan, M. A., Milasta, S., & Green, D. R. (2009). Toll-like receptor signaling in the lysosomal pathways. Immunology Reviews, 227(1), 203-220.
26. Majumdar, A., Cruz, D., Asamoah, N., et al. (2007). Activation of microglia acidifies lysosomes and leads to degradation of Alzheimer amyloid fibrils. Molecular Biology of the Cell, 18(4), 1490-1496.
27. Hao, W., Liu, Y., Liu, S., et al. (2011). Myeloid differentiation factor 88-deficient bone marrow cells improve Alzheimer's disease-related symptoms and pathology. Brain, 134(Pt 1), 278-292.